ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

JBDI vs IDXG // ENTERPRISE SCALE & MARKET CAP

JBDI Holdings Limited (NASDAQ) VS. Interpace Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: JBDI 2 — IDXG 6
▲ ENTERPRISE SCALE & MARKET CAP LEADER: IDXG
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JBDI VS. IDXG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC JBDI IDXG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 49.90% 62.30% -12.40 IDXG /gross-margins <GO>
Return on Invested Capital (ROIC) — 16.20% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 4.7x — TIE /valuation <GO>
Free Cash Flow Yield -2.01% 23.60% -25.61 IDXG /fcf-yield <GO>
Operating Margin -2.00% 10.50% -12.50 IDXG /operating-margins <GO>
Net Profit Margin 1.40% 63.50% -62.10 IDXG /net-margins <GO>
Revenue Growth (YoY) 0.90% -17.50% +18.40 JBDI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 6/9 -3.00 IDXG /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.6 51.5 +9.10 JBDI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $22.9M $23.2M -$268.0K IDXG /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR JBDI REV IDXG REV JBDI GROSS % IDXG GROSS % JBDI FCF IDXG FCF
FY 2025 $8.5M $38.7M 49.9% 62.3% -$462.0K $5.5M
FY 2024 $8.4M $46.9M 39.7% 63.8% -$3.4M $3.8M
FY 2023 $9.4M $40.0M — — $1.0M $3.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JBDI // BETA —
IDXG // BETA —